£3.72
0.05% yesterday
London, Dec 24, 01:35 pm CET
ISIN
GB00BMX86B70
Symbol
HLN
Index

Haleon Stock price

£3.72
+0.01 0.13% 1M
-0.08 2.14% 6M
+0.02 0.47% YTD
-0.03 0.84% 1Y
+0.64 20.71% 3Y
+0.58 18.55% 5Y
+0.58 18.55% 10Y
+0.58 18.55% 20Y
London, Closing price Wed, Dec 24 2025
+0.00 0.05%
ISIN
GB00BMX86B70
Symbol
HLN
Index
Industry

New AI Insights on Haleon Insights AI Insights on Haleon

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
£33.1b
Enterprise Value
£40.9b
Net debt
£7.8b
Cash
£676.0m
Shares outstanding
9.0b
Valuation (TTM | estimate)
P/E
- | 19.7
P/S
- | 2.9
EV/Sales
- | 3.6
EV/FCF
19.0
P/B
2.1
Dividends
DPS
£0.06
Yield 1Y | 5Y
1.7% | 0.7%
Growth 1Y | 5Y
47.6% | -
Payout 1Y | 3Y
38.8% | 27.4%
Increased
2 Years
Financials (TTM | estimate)
Revenue
- | £11.4b
EBITDA
- | £2.8b
EBIT
- | £2.5b
Net Income
- | £1.7b
Free Cash Flow
£2.2b
Growth (TTM | estimate)
Revenue
- | 1.5%
EBITDA
- | 9.3%
EBIT
- | -1.0%
Net Income
- | 17.9%
Free Cash Flow
13.9%
Margin (TTM | estimate)
Gross
-
EBITDA
- | 25.0%
EBIT
-
Net
- | 14.9%
Free Cash Flow
-
Financial Health
Equity Ratio
47.1%
Return on Equity
8.9%
ROCE
-
ROIC
-
Debt/Equity
0.5
More
EPS
-
FCF per Share
£0.2
Short interest
50.0%
Employees
25k
Rev per Employee
£460.0k
Show more

Is Haleon a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.

Haleon Stock Analysis

Unlock Scores for Free

Analyst Opinions

24 Analysts have issued a Haleon forecast:

17x Buy
71%
6x Hold
25%
1x Sell
4%

Analyst Opinions

24 Analysts have issued a Haleon forecast:

Buy
71%
Hold
25%
Sell
4%

Financial data from Haleon

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
11,233 11,233
1% 1%
100%
- Direct Costs 4,409 4,409
1% 1%
39%
6,824 6,824
2% 2%
61%
- Selling and Administrative Expenses 4,452 4,452
3% 3%
40%
- Research and Development Expense 298 298
4% 4%
3%
2,530 2,530
3% 3%
23%
- Depreciation and Amortization 324 324
5% 5%
3%
EBIT (Operating Income) EBIT 2,206 2,206
4% 4%
20%
Net Profit 1,442 1,442
37% 37%
13%

In millions GBP.

Don't miss a Thing! We will send you all news about Haleon directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Haleon Plc provides personal healthcare products. The firm focus on consumer healthcare and driven by its purpose of delivering better everyday health with humanity. Its brands are built on science, innovation and human understanding and are trusted by millions of consumers globally. The company is headquartered in Brentford, the United Kingdom.

Head office United Kingdom
CEO Brian McNamara
Employees 24,561
Founded 2021
Website www.haleon.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today